
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (35): 4394-4398.DOI: 10.12114/j.issn.1007-9572.2022.0557
Special Issue: 高血压最新文章合辑
• Article • Previous Articles Next Articles
Received:2022-07-13
Revised:2022-08-22
Published:2022-12-15
Online:2022-09-15
Contact:
LIAN Qiufang
About author:
通讯作者:
廉秋芳
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0557
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 |
|---|---|---|---|---|---|---|---|---|
| 非HUA组 | 166 | 72/94 | 54.6±10.8 | 25.1±3.1 | 149±20 | 90±13 | 35(21.1) | 18(10.8) |
| 合并HUA组 | 101 | 63/38 | 48.0±13.5 | 27.0±3.4 | 154±19 | 95±14 | 33(32.7) | 20(19.8) |
| t(χ2)值 | 9.071a | 4.155 | -4.769 | -1.952 | -2.801 | 4.443a | 4.129a | |
| P值 | 0.003 | <0.001 | <0.001 | 0.052 | 0.005 | 0.035 | 0.042 |
Table 1 Comparison of general data between non-HUA and HUA euthyroid patients with essential hypertension
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 |
|---|---|---|---|---|---|---|---|---|
| 非HUA组 | 166 | 72/94 | 54.6±10.8 | 25.1±3.1 | 149±20 | 90±13 | 35(21.1) | 18(10.8) |
| 合并HUA组 | 101 | 63/38 | 48.0±13.5 | 27.0±3.4 | 154±19 | 95±14 | 33(32.7) | 20(19.8) |
| t(χ2)值 | 9.071a | 4.155 | -4.769 | -1.952 | -2.801 | 4.443a | 4.129a | |
| P值 | 0.003 | <0.001 | <0.001 | 0.052 | 0.005 | 0.035 | 0.042 |
| 组别 | 例数 | TC( | TG〔M(QR),mmol/L〕 | HDL-C( | LDL-C( | Scr( | SUA( | TSH( | FT3( | FT4( |
|---|---|---|---|---|---|---|---|---|---|---|
| 非HUA组 | 166 | 4.12±0.96 | 1.39(0.94) | 1.08±0.25 | 2.57±0.80 | 67.90±12.72 | 276.76±65.30 | 2.34±0.88 | 4.59±0.60 | 16.73±2.33 |
| 合并HUA组 | 101 | 4.40±0.97 | 2.16(1.40) | 1.03±0.27 | 2.80±0.81 | 77.22±15.69 | 459.98±70.58 | 2.27±0.98 | 5.00±0.69 | 16.96±2.29 |
| t(Z)值 | -2.279 | -4.900a | 1.532 | -2.284 | -5.306 | -21.560 | 0.623 | -5.066 | -0.782 | |
| P值 | 0.003 | <0.001 | 0.127 | 0.023 | <0.001 | <0.001 | 0.534 | <0.001 | 0.435 |
Table 2 Comparison of biochemical indices between non-HUA and HUA euthyroid patients with essential hypertension
| 组别 | 例数 | TC( | TG〔M(QR),mmol/L〕 | HDL-C( | LDL-C( | Scr( | SUA( | TSH( | FT3( | FT4( |
|---|---|---|---|---|---|---|---|---|---|---|
| 非HUA组 | 166 | 4.12±0.96 | 1.39(0.94) | 1.08±0.25 | 2.57±0.80 | 67.90±12.72 | 276.76±65.30 | 2.34±0.88 | 4.59±0.60 | 16.73±2.33 |
| 合并HUA组 | 101 | 4.40±0.97 | 2.16(1.40) | 1.03±0.27 | 2.80±0.81 | 77.22±15.69 | 459.98±70.58 | 2.27±0.98 | 5.00±0.69 | 16.96±2.29 |
| t(Z)值 | -2.279 | -4.900a | 1.532 | -2.284 | -5.306 | -21.560 | 0.623 | -5.066 | -0.782 | |
| P值 | 0.003 | <0.001 | 0.127 | 0.023 | <0.001 | <0.001 | 0.534 | <0.001 | 0.435 |
| 变量 | 赋值 |
|---|---|
| EH患者发生HUA | 0=否,1=是 |
| 性别 | 0=女,1=男 |
| 年龄 | 实测值 |
| BMI | 实测值 |
| DBP | 实测值 |
| 吸烟史 | 0=否,1=是 |
| 饮酒史 | 0=否,1=是 |
| TC | 实测值 |
| TG | 实测值 |
| LDL-C | 实测值 |
| Scr | 实测值 |
| FT3 | 实测值 |
Table 3 Variable assignment table for multivariate Logistic regression analysis
| 变量 | 赋值 |
|---|---|
| EH患者发生HUA | 0=否,1=是 |
| 性别 | 0=女,1=男 |
| 年龄 | 实测值 |
| BMI | 实测值 |
| DBP | 实测值 |
| 吸烟史 | 0=否,1=是 |
| 饮酒史 | 0=否,1=是 |
| TC | 实测值 |
| TG | 实测值 |
| LDL-C | 实测值 |
| Scr | 实测值 |
| FT3 | 实测值 |
| 变量 | β | SE | Waldχ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 男性 | 1.045 | 0.475 | 4.839 | 0.028 | 2.843 | (1.121,7.215) |
| 年龄 | -0.042 | 0.015 | 7.334 | 0.007 | 0.959 | (0.931,0.989) |
| BMI | 0.119 | 0.050 | 5.564 | 0.018 | 1.126 | (1.020,1.234) |
| TG | 0.601 | 0.173 | 12.084 | 0.001 | 1.824 | (1.300,2.560) |
| LDL-C | 1.031 | 0.452 | 5.210 | 0.022 | 2.804 | (1.157,6.795) |
| Scr | 0.069 | 0.015 | 22.049 | <0.001 | 1.071 | (1.041,1.102) |
| FT3 | 0.831 | 0.280 | 8.808 | 0.003 | 2.297 | (1.326,3.977) |
Table 4 Multivariate Logistic regression analysis of influencing factors of HUA in euthyroid patients with essential hypertension
| 变量 | β | SE | Waldχ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 男性 | 1.045 | 0.475 | 4.839 | 0.028 | 2.843 | (1.121,7.215) |
| 年龄 | -0.042 | 0.015 | 7.334 | 0.007 | 0.959 | (0.931,0.989) |
| BMI | 0.119 | 0.050 | 5.564 | 0.018 | 1.126 | (1.020,1.234) |
| TG | 0.601 | 0.173 | 12.084 | 0.001 | 1.824 | (1.300,2.560) |
| LDL-C | 1.031 | 0.452 | 5.210 | 0.022 | 2.804 | (1.157,6.795) |
| Scr | 0.069 | 0.015 | 22.049 | <0.001 | 1.071 | (1.041,1.102) |
| FT3 | 0.831 | 0.280 | 8.808 | 0.003 | 2.297 | (1.326,3.977) |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
万强,高艳霞,吴燕升,等. 高尿酸血症与心血管疾病关系的研究进展[J]. 中西医结合心脑血管病杂志,2018,16(1):54-56. DOI:10.3969/j.issn.1672-1349.2018.01.012.
|
| [5] |
董婷,李建中,胡楠,等. 苏州市斜塘社区高尿酸血症人群慢性肾脏病筛查及危险因素分析[J]. 中国血液流变学杂志,2021,31(3):327-332. DOI:10.3969/j.issn.1009-881X.2021.03.007.
|
| [6] |
黄雨晴,张莹,莫与京,等. 原发性老年高血压患者高尿酸血症患病率的调查研究[J]. 中华老年心脑血管病杂志,2015,17(5):530-531. DOI:10.3969/j.issn.1009-0126.2015.05.025.
|
| [7] |
|
| [8] | |
| [9] |
|
| [10] |
|
| [11] |
王新,郭静华. 甲状腺素对老年亚临床甲状腺功能减退患者血脂、血糖、血尿酸水平的影响[J]. 中国老年学杂志,2014,34(3):637-639. DOI:10.3969/j.issn.1005-9202.2014.03.031.
|
| [12] |
|
| [13] |
中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24 (1):24-56. DOI:10.3969/j.issn.1007-5410.2019.01.002.
|
| [14] |
孙明姝,母义明,赵家军,等. 中国临床指南现状分析及《中国高尿酸血症与痛风诊治指南(2018)》制定介绍[J]. 中华内分泌代谢杂志,2019,35(3):181-184. DOI:10.3760/cma.j.issn.1000-6699.2019.03.001.
|
| [15] |
张丹丹. 邯郸地区妊娠期甲状腺功能正常参考值建立[D]. 邯郸:河北工程大学,2020.
|
| [16] |
|
| [17] |
陈蕾,伍成凯,康峻鸣,等. 我国45岁及以上中老年人群高尿酸血症与常见慢性病的关联研究[J]. 中国全科医学,2021,24(4):447-452. DOI:10.12114/j.issn.1007-9572.2020.00.599.
|
| [18] |
|
| [19] |
|
| [20] |
曹青松,李向旭,马楠,等. 原发性甲状腺功能减退症对尿酸水平的影响[J]. 河南医学研究,2020,29(17):3130-3132. DOI:10.3969/j.issn.1004-437X.2020.17.018.
|
| [21] | |
| [22] |
卢雪婷,于祥远,秦林原,等. 13675例体检者高尿酸血症的检出率及其与体重指数、血脂、血糖的相关性研究[J]. 现代预防医学,2015,42(4):713-716.
|
| [23] |
仝小玲,张连文. 中青年人群高尿酸血症的发病特征及影响因素分析[J]. 中国医刊,2021,56(8):864-868. DOI:10.3969/j.issn.1008-1070.2021.08.015.
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [1] | LIU Tianyuan, SANG Wanyue, PENG Jiping, CHENG Siyi, HUANG Yiyi, LI Ouwen, JIANG Hong, ZHOU Xiaoya. Correlation Analysis between Neurofilament Light Chain and the Risk of Left Ventricular Hypertrophy in Patients with Nocturnal Hypertension [J]. Chinese General Practice, 2026, 29(15): 2014-2021. |
| [2] | WU Zhiyuan, WANG Chuanxu, YANG Feng, ZHANG Xuming, ZHOU Jiabao, GAO Jiandong. Study on the Mechanism of Shizhi Fang in Uric Acid Transport-related Proteins in Hyperuricemia [J]. Chinese General Practice, 2026, 29(14): 1898-1910. |
| [3] | WANG Siman, ZHANG Mengchu, LI Wen, XU Ai, XU Jin, GUO Rui, YAN Haixia. Research on the Construction of a Risk Prediction Model for Primary Hypertension with Left Ventricular Hypertrophy Based on TCM Syndromes and Pulse Graph Parameters [J]. Chinese General Practice, 2026, 29(14): 1840-1848. |
| [4] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [5] | ZHANG Qiuyu, HU Xiaoyong, TANG Rui, LI Hongjian. Correlation between Chinese Visceral Adiposity Index and Nocturnal Hypertension in Young and Middle-aged People [J]. Chinese General Practice, 2026, 29(07): 872-878. |
| [6] | ZHU Chenrui, LI Na, WU Yuntao, ZHAO Haiyan, HUANG Zhe, LIU Yan, JI Chunpeng, WU Shouling. The Impact of Serum Uric Acid Levels on New-onset Atrioventricular Block: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(05): 583-590. |
| [7] | LI Jixin, QIU Linjie, REN Yan, WANG Wenru, YANG Zhenyu, LIU Fengzhao, LI Meijie, LI Wenjie, ZHANG Jin. Correlation of Muscle-fat Ratio with Non-obese Hyperuricaemia and the Predictive Value [J]. Chinese General Practice, 2026, 29(01): 84-90. |
| [8] | XIANG Fengling, WANG Yuankun, WANG Xiaoyan, HE Shengjie, GAN Jinhua. The Prevalence of Hyperuricemia among Children and Adolescents in China: a Meta-analysis [J]. Chinese General Practice, 2025, 28(33): 4206-4213. |
| [9] | YANG Bingqing, YANG Tianyuan, HOU Chenxue, WANG Qi. Comparative Study on the Potential of Non-invasive Models in Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Combined with Non-alcoholic Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(32): 4067-4074. |
| [10] | DAI Tiangu, HE Qing, GAO Xuefei, ZHANG Gaoyu, FAN Jiarong, WANG Zihan, XIAO Xiang, LI Lin. The Predictive Value of Combined Detection of Brachial-ankle Pulse Wave Velocity, Serum Total Cholesterol and N-terminal Pro-B-type Natriuretic Peptide for Coronary Heart Disease in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(32): 4061-4066. |
| [11] | ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659. |
| [12] | MA Wenyuan, QI Shuo, SHANG Jianwei, CHEN Xiaoheng, LI Zhe, LI Huilong, HU Rui, LI Lu, SI Xinying, DING Zhiguo. Preliminary Development of a TCM Syndrome Evaluation Scale for Hashimoto's Thyroiditis with Normal Thyroid Function: Based on Expert Consultation and Clinical Survey [J]. Chinese General Practice, 2025, 28(28): 3590-3600. |
| [13] | ZHOU Penglong, CHANG Jing, DING Suying, CHEN Jingfeng, WANG Tao, LI Chenyang. Correlation Analysis between Age-Stratified Differences in Fat-to-muscle Ratio and Hyperuricemia [J]. Chinese General Practice, 2025, 28(27): 3375-3384. |
| [14] | LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233. |
| [15] | SU Jun, WANG Jiamin, SUN Xiaojie. The Relationship between Health Literacy and Online Health Information Search among Caregivers of Pediatric Oncology Children [J]. Chinese General Practice, 2025, 28(10): 1207-1212. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||